During programmed cell death, apoptotic cells are recognized and rapidly engulfed by phagocytes. Although a number of genes have been identified that promote cell corpse engulfment, it is not well understood how phagocytosis of apoptotic cells is negatively regulated. Here we have identified Caenorhabditis elegans myotubularin MTM-1 as a negative regulator of cell corpse engulfment. Myotubularins (MTMs) constitute a large, highly conserved family of lipid phosphatases. MTM gene mutations are associated with various human diseases, but the cellular functions of MTM proteins are not clearly defined. We found that inactivation of MTM-1 caused significant reduction in cell corpses in strong loss-of-function mutants of ced-1, ced-6, ced-7, and ced-2, but not in animals deficient in the ced-5, ced-12, or ced-10 genes. In contrast, overexpression of MTM-1 resulted in accumulation of cell corpses. This effect is dependent on the lipid phosphatase activity of MTM-1. We show that loss of mtm-1 function accelerates the clearance of cell corpses by promoting their internalization. Importantly, the reduction of cell corpses caused by mtm-1 RNAi not only requires the activities of CED-5, CED-12, and CED-10, but also needs the functions of the phosphatidylinositol 3-kinases (PI3Ks) VPS-34 and PIKI-1. We found that MTM-1 localizes to the plasma membrane in several known engulfing cell types and may modulate the level of phosphatidylinositol 3-phosphate (PtdIns(3)P) in vivo. We propose that MTM-1 negatively regulates cell corpse engulfment through the CED-5/CED-12/CED-10 module by dephosphorylating PtdIns(3)P on the plasma membrane.
Clearance of dead cells is crucial for normal animal development. Cell corpses are recognized, engulfed, and removed by phagocytic cells. However, the mechanisms that regulate phagocytosis are still not well understood, especially the ways in which the process is inhibited (negatively regulated). We screened the nematode worm Caenorhabditis elegans for negative regulators of cell corpse engulfment and identified myotubularin MTM-1. Myotubularins (MTMs) are a family of highly conserved enzymes that remove phosphate groups from membrane lipids. Mutations in human MTM genes are associated with various severe diseases including X-linked myotubular myopathy and Charcot-Marie-Tooth disease, but the normal functions of MTMs are unknown. In this study, we found that MTM-1 inhibits cell corpse engulfment through a series of evolutionarily conserved signaling molecules (the bipartite GEF (CED-5/DOCK180-CED-12/ELMO) and the GTPase CED-10/Rac). The negative regulatory effect of MTM-1 requires both its lipid phosphatase activity and the function of another group of enzymes called PI3-kinases. We propose that MTM-1 acts through Rac GTPase CED-10 by dephosphorylating the lipid PtdIns(3)P on the plasma membrane. We have identified a negative regulatory mechanism of cell corpse engulfment and a previously unknown cellular function of MTM-1, which may provide further insights into the basis of human MTM-related diseases.
Citation: Zou W, Lu Q, Zhao D, Li W, Mapes J, et al. (2009) Caenorhabditis elegans Myotubularin MTM-1 Negatively Regulates the Engulfment of Apoptotic Cells. PLoS Genet 5(10): e1000679. doi:10.1371/journal.pgen.1000679
Editor: Andrew D. Chisholm, University of California San Diego, United States of America
Received: June 1, 2009; Accepted: September 7, 2009; Published: October 9, 2009
Copyright: © 2009 Zou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National High Technology Project 863 from the Ministry of Science and Technology, grant number: 2007AA02Z1A0, www.most.gov.cn. The funders has no role in study design, data, collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Phagocytosis of apoptotic cells is essential for animal development, tissue homeostasis and regulation of immune responses. Defects in this process contribute to the development of various human diseases including persistent inflammatory diseases and autoimmune disorders . In C. elegans, phagocytosis of apoptotic cells is controlled by two partially redundant signaling pathways. In one pathway, three genes, ced-1, ced-7 and ced-6, are involved in recognizing and transducing the engulfment signal(s), while dyn-1 acts downstream of them to promote vesicle delivery for cell corpse internalization –. In the other pathway, several evolutionarily conserved intracellular signaling molecules, CED-2/CrkII, CED-5/Dock180 and CED-12/ELMO, act downstream of PSR-1, the C. elegans homologue of the human phosphatidylserine receptor. These signaling molecules mediate activation of the small GTPase CED-10/Rac, leading to rearrangement of the actin cytoskeleton which is needed for cell corpse engulfment –. In addition, CED-10/Rac may also function downstream of the CED-1/6/7 pathway to mediate the engulfment of apoptotic cells . CED-2 belongs to the Crk family whose members are widely expressed adaptor proteins that mediate the formation of protein complexes for signal transduction in response to various extracellular stimuli . However, the way in which CED-2 functions to regulate cell corpse engulfment is not well understood. Biochemical studies in mammalian cells indicate that DOCK180/CED-5 and ELMO/CED-12 function as an unconventional bipartite nucleotide exchange factor for Rac/CED-10 activation, which leads to cytoskeleton reorganization during engulfment . Moreover, an UNC-73/TRIO-MIG-2/RhoG signaling module regulates CED-10/Rac activation through its interaction with the armadillo repeat of CED-12/ELMO . However, no defect in cell corpse engulfment was observed in animals which completely lose the activity of either mig-2 or unc-73 or both, indicating that more complex regulatory mechanisms are involved in CED-10/Rac activation. In addition, as earlier studies mainly focused only on positive regulation of engulfment, it is less well understood whether any negative regulatory mechanism is involved.
Myotubularin phosphatases belong to the tyrosine/dual-specificity phosphatase super-family (PTP/DSP) whose members have been found in almost all eukaryotes. Mutations in myotubularin genes are associated with several human diseases . For example, mutations in MTM1, the founder member of this family, cause X-linked myotubular myopathy (XLMTM), a severe congenital muscular disorder. Mutations in MTMR2 and MTMR13 are associated with Charcot-Marie-Tooth disease (CMT4B1) –. The hallmark of the protein tyrosine phosphatase (PTP) super-family is an active site motif (CX5R). Intriguingly, nearly half of the known MTM1-related proteins (MTMRs) carry sequence variations in this motif and are predicted to be catalytically inactive . Nevertheless, these inactive MTMRs are also evolutionarily conserved and have essential biological functions. Recently, several active-inactive pairings of myotubularins have been identified which appear to be important for the function of the active myotubularins, indicating that the inactive MTMRs likely serve as regulatory units for the active ones –.
Surprisingly, instead of acting as protein tyrosine phosphatases, MTM1 and its related proteins were later found to function primarily as lipid phosphatases with specificity for phosphatidylinositol 3-phosphate (PtdIns(3)P) and its metabolite phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2) –. PtdIns(3)P is mainly generated by the Class III PI3-kinase VPS34 in vivo, and can be further modified by the phosphatidylinositol 3-phosphate 5-kinase PIKFYVE to generate PtdIns(3,5)P2 . Both PtdIns(3)P and PtdIns(3,5)P2 are key regulators of the endocytic pathway . Therefore, the identification of MTM1 and MTMRs as lipid phosphatases that use PtdIns(3)P and PtdIns(3,5)P2 as substrates suggests that they may regulate endocytosis and/or other class III PI3-kinase-mediated cellular events. This idea is supported by evidence from a variety of experiments in yeast and C. elegans. Overexpression of human MTM1 decreased the level of PtdIns(3)P in S. pombe and induced a vacuolar phenotype similar to that of mutants defective in VPS34 . Ymr1p, the sole myotubularin in yeast, cooperates with the synaptojanin-like PI phosphatase Sjl3p to regulate PtdIns(3)P levels and vesicular transport . Reduction of C. elegans mtm-6 activity by RNAi rescued the larval lethality of vps-34(lf) mutants, while inactivation of mtm-1 rescued the endocytosis defect in vps-34(lf) coelomocytes (the specialized cells that constantly take up fluid and macromolecules from the body cavity), indicating that myotubularins likely modulate VPS-34-mediated cellular processes in worms . In addition, MTM-6, an active MTM, was found to act together with MTM-9, a catalytically inactive MTM, to regulate an ARF-6 and RME-1-mediated endocytic pathway . However, it is not known how C. elegans MTM-1 regulates endocytosis or whether it functions in other cellular processes by regulating PtdIns(3)P.
On the other hand, the cellular function of MTM1 in mammals appears to be more obscure. In one study, it was reported that MTM1 translocates to late endosomes after EGF stimulation and negatively regulates EGFR degradation and vesicular formation at the late stage of endosomal trafficking . This process is mediated through interaction between the MTM1 PH-GRAM domain and PtdIns(3,5)P2 . In another study, however, MTM1 siRNA caused increased PtdIns(3)P levels and accumulation of EGFR in early but not late endosomes, whereas MTMR2 RNAi resulted in elevated PtdIns(3)P levels and EGFR accumulation in late endosomes . This suggested that MTM1 and MTMR2 function sequentially in the endocytic pathway with MTM1 acting in an early step . Therefore, the cellular functions of MTM1 either in endocytic transport or in other cellular events still remain elusive.
In the present study, we have identified C. elegans MTM-1 as a negative regulator of cell corpse engulfment. We found that inactivation of MTM-1 by RNAi promotes cell corpse engulfment, whereas overexpression of MTM-1 results in accumulation of cell corpses in a manner dependent on its lipid phosphatase activity. We show that the reduction of cell corpses caused by mtm-1 RNAi requires the functions of CED-5, CED-12 and CED-10 and the activities of PI3-kinases VPS-34 and PIKI-1. MTM-1 is widely expressed in many cell types, localizes to the plasma membrane and negatively regulates the vesicular accumulation of PtdIns(3)P in C. elegans. Our data suggest that MTM-1 acts as a lipid phosphatase to negatively regulate cell corpse engulfment through the CED-5/CED-12/CED-10 module, which is likely achieved by dephosphorylating PtdIns(3)P on the plasma membrane.
Isolation of mtm-1 as a negative regulator of cell corpse engulfment
To identify negative regulators of cell corpse engulfment, we performed an RNAi screen to search for genes which when inactivated cause a reduction in the number of cell corpses in ced-1(e1735) mutants (Materials and Methods). mtm-1 was one of the candidate genes identified from this screen because the accumulation of cell corpses in ced-1(e1735);rrf-3(pk1426) double mutants was significantly reduced when treated with mtm-1 RNAi (Table 1; Materials and Methods). Interestingly, a similar reduction in cell corpses was also observed in strong loss-of-function mutants of ced-6, ced-7, ced-2 after mtm-1 RNAi treatment, but not in animals with mutations in the ced-5, ced-12 or ced-10 genes (Table 1). The RNAi treatment likely caused a specific inactivation of the mtm-1 gene as injection of an in vitro-synthesized dsRNA of mtm-1 resulted in a similar reduction of cell corpses in ced-1(e1735) mutants (Figure S1A; Materials and Methods). Moreover, MTM-1::GFP expression was greatly reduced after mtm-1 RNAi treatment, either by injecting in vitro-synthesized mtm-1 dsRNA or by feeding with bacteria expressing mtm-1 dsRNA (Figure S1A). To further confirm the RNAi results, we also analyzed an mtm-1 deletion mutant, ok742, which contains a 1314 bp deletion that removes the region from intron 4 to exon 7 of the mtm-1 gene (Figure S1B). ok742 causes embryonic lethality and early larval arrest, indicating that mtm-1 is essential for embryonic and larval development in C. elegans. We examined the appearance of cell corpses in ok742 homozygous embryos derived from ok742/+ mothers (ht2/mtm-1(ok742)) and found that it was indistinguishable from that in wild-type embryos (Table 1). However, consistent with the RNAi results, mtm-1(ok742) deletion mutants caused significant reduction in cell corpses in ced-2(n1994) mutants, but not in ced-5(n1812) or ced-10(n3246) mutants (Table 1). Moreover, similar reduction of cell corpses by mtm-1 RNAi was also observed in ced-1(e1735);ced-2(n1994) double mutants, but not in ced-1(e1735);ced-5(n1812), ced-1(e1735)ced-12(n3261) or ced-1(e1735);ced-10(n3246) double mutants (Table 1). These data suggest that mtm-1 likely antagonizes cell corpse engulfment in a way that requires the activity of ced-5, ced-12 and ced-10. In agreement with this notion, overexpression of MTM-1 driven by C. elegans heat-shock promoters (qxIs156: Phspmtm-1) led to accumulation of cell corpses at every embryonic stage (Figure 1A). The engulfment defect caused by mutations in the ced-2, ced-5, ced-12 or ced-10 genes was not further enhanced by overexpression of MTM-1, whereas significantly more cell corpses were observed in loss-of-function mutants of ced-1, ced-6 and ced-7 which overexpressed MTM-1, indicating that MTM-1 negatively regulates cell corpse engulfment and likely acts through the CED-5/CED-12/CED-10 module (Figure 1B). Since mig-2 modulates the CED-10/Rac pathway through CED-12/CED-5 GEF and seems to act in parallel to ced-2 , we tested whether loss of mtm-1 function could reduce cell corpses when mig-2 function was lost. We found that mtm-1 RNAi resulted in reduced numbers of cell corpses in both ced-1(e1735);mig-2(mu28) and ced-2(n1994);mig-2(mu28) double mutants, suggesting that an additional input of the CED-10/Rac pathway in parallel to mig-2 and ced-2 may exist and mtm-1 probably functions downstream of them to inhibit the CED-5/CED-12/CED-10 module (Table 1). Consistent with this idea, we observed a significant reduction in cell corpses by mtm-1 RNAi in a weak loss-of-function mutant of ced-10, ced-10(n1993), in which ced-10 activity is only partially blocked (Table 1).
Figure 1. Overexpression of MTM-1 results in accumulation of cell corpses.
(A) Time-course analysis was performed in wild type (no heat-shock treatment: black; after heat-shock treatment: gray), qxIs156 (PhspMTM-1; light gray) and qxIs210 (PhspMTM-1(C378S); hatching). Cell corpses were scored at the following embryonic stages: bean/comma (comma), 1.5-fold (1.5F), 2-fold (2F), 2.5-fold (2.5F), 3-fold (3F) and 4-fold (4F). At least 15 embryos were scored at every stage; error bars indicate s.e.m. Data derived from wild type with and without heat-shock treatment, wild type and qxIs156 or wild type and qxIs210 at multiple developmental stages were compared by two-way analysis of variance. Post-hoc comparisons were done by Fisher's PLSD (protected least squares difference). *P<0.05, **P<0.0001. All other points had P values>0.05. (B) Cell corpses in the indicated strains were scored at the 4-fold embryonic stage. At least 15 embryos were scored; error bars indicate s.e.m. Data were compared by unpaired t tests. **P<0.0001; other points had P value>0.05. In (A) and (B), heat-shock experiments were performed as described in Materials and Methods.doi:10.1371/journal.pgen.1000679.g001
Table 1. mtm-1 negatively regulates cell corpse engulfment through ced-5/12/10.doi:10.1371/journal.pgen.1000679.t001
Loss of mtm-1 function promotes the internalization of cell corpses
To further investigate whether the reduction in cell corpses caused by inactivation of mtm-1 is due to an accelerated clearance of cell corpses, we performed a time-lapse analysis to follow cell corpse duration in qx17, a weak loss-of-function allele of the ced-6 gene which showed a mild engulfment defect on its own and a reduced number of cell corpses after mtm-1 RNAi treatment (Table 1; Materials and Methods). In ced-6(qx17) animals treated with control RNAi, most cell corpses persisted from 30 to 70 min, with an average duration of 63 min (Figure 2A). In contrast, in ced-6(qx17) embryos treated with mtm-1 RNAi, most cell corpses persisted from 20 to 40 min, with an average duration of 34 min, which is 46% shorter than in control animals (Figure 2A). This suggests that mtm-1 RNAi may promote cell corpse clearance. We next examined the embryonic cell deaths that occurred during a period of 200–400 min past the first cleavage. We observed similar numbers of cell death events in qx17 animals treated with either control or mtm-1 RNAi, indicating that mtm-1 RNAi does not obviously affect the occurrence of cell death (Figure 2B). Consistent with this, no missing or extra cells were observed in the anterior pharynx of ced-6(qx17) animals treated with either control or mtm-1 RNAi (data not shown). Therefore, inactivation of mtm-1 accelerates the clearance of cell corpses.
Figure 2. Inactivation of MTM-1 accelerates cell corpse clearance.
(A) Four-dimensional microscopy analysis of cell corpse duration was performed in ced-6(qx17) mutants (black) or ced-6(qx17);mtm-1(RNAi) worms (gray). The duration of 33 cell corpses in ced-6(qx17) animals (n = 4) and 35 cell corpses in ced-6(qx17);mtm-1(RNAi) animals (n = 3) was monitored. The numbers in parenthesis indicate the average duration of cell corpses (±s.e.m). The y-axis represents the number of cell corpses within a specific duration range as shown on the x-axis. (B) mtm-1 RNAi does not affect cell death occurrence. Embryonic cell deaths occurring between 200 and 400 min post first cleavage were followed in ced-6(qx17) mutants treated with either control RNAi (black) or mtm-1 RNAi (gray). The y-axis indicates the total number of cell death events observed at different time points as shown on the x-axis.doi:10.1371/journal.pgen.1000679.g002
ced-1 encodes a transmembrane phagocytic receptor that acts specifically in engulfing cells to mediate the recognition and internalization of cell corpses . In wild-type animals, CED-1::GFP was detected along the surface of apoptotic cells, which are distinguishable using Nomarski optics , (Figure 3A; Figure S2A). Moreover, we found that clustering of CED-1::GFP around cell corpses completely overlapped with a secreted Annexin V::mRFP fusion protein expressed under the control of heat-shock promoters (Phspannexin v::mrfp) (Figure S2A). Annexin V specifically labels apoptotic cells by binding to phosphatidylserine (PS), an “eat me” signal which appears only on the surface of dying cells –. In fact, over 96% of cell corpses were found to be labeled by the secreted Annexin V::mRFP in both wild type and ced-6(qx17) mutants (at least 15 embryos were scored in each strain). We therefore used CED-1::GFP as a marker to examine whether the acceleration of cell corpse clearance caused by mtm-1 RNAi is achieved by facilitating the internalization of apoptotic cells. We found that more cell corpses were surrounded by CED-1::GFP in ced-6(qx17) animals treated with mtm-1 RNAi, suggesting that more apoptotic cells might be internalized (Figure 3B). A similar increase in CED-1::GFP clustering by mtm-1 RNAi was also observed in the strong loss-of-function mutants of ced-6 and ced-2, but not ced-5 (Figure S3A). Since CED-1 is a phagocytic receptor that localizes to extending pseudopods and only transiently associates with nascent phagosomes after engulfment ,, we further examined the internalization of cell corpses by monitoring both the formation and duration of the CED-1::GFP ring around cell corpses. We found that in ced-6(qx17) animals treated with mtm-1 RNAi, the CED-1::GFP ring formed rapidly around dying cells, in an average of 4.5 min (Figure 4A and 4B; Video S1). In control RNAi-treated ced-6(qx17) embryos, however, many cell corpses were not fully surrounded by CED-1::GFP even after 10 min and the average formation time of a full CED-1::GFP ring was 7.4 min, which is 64% longer than that in mtm-1 RNAi-treated embryos (Figure 4A and 4B; Video S2). Moreover, we observed that CED-1::GFP associated with extending pseudopods or nascent phagosomes for an average duration of 29 min in control animals, compared to an average of just 15 min in ced-6(qx17);mtm-1(RNAi) embryos (Figure 4C and 4D; Video S3, Video S4). To exclude the possibility that the observed effect in cell corpse engulfment by mtm-1 RNAi is caused by the individual variability of different apoptotic cells or different developmental locations, we also monitored the clearance of a specific apoptotic cell C3, which undergoes apoptosis at a mid-embryonic stage and is engulfed by a ventral hypodermal cell , (Figure S2A). We found that both formation and duration of the CED-1::GFP ring around C3 were significantly shortened after mtm-1 RNAi treatment, indicating that the internalization of C3 was accelerated similar to other apoptotic cells (Figure S2B, S2C). Collectively, these data suggest that inactivation of MTM-1 promotes cell corpse internalization in ced-6(qx17) mutants.
Figure 3. Loss of mtm-1 function promotes the internalization of cell corpses.
(A) DIC and fluorescence images of wild-type embryos expressing CED-1::GFP (i, ii), ACT-5::GFP (iii, iv), GFP::RAB-7 (v, vi) or LMP-1::GFP (vii, viii) are shown. Cell corpses surrounded by GFP are indicated by arrows. Bars, 5 µm. (B) The percentage of cell corpses encircled by CED-1::GFP, ACT-5::GFP, GFP::RAB-7 or LMP-1::GFP was quantified in ced-6(qx17) embryos treated with either control (black bar) or mtm-1 RNAi (gray bar). At least 17 1.5-fold stage embryos were scored; error bars indicate s.e.m. Unpaired t tests were performed to compare the data. **P<0.0001.doi:10.1371/journal.pgen.1000679.g003
Figure 4. mtm-1 RNAi accelerates the engulfment of cell corpses.
(A) The formation of CED-1::GFP rings around cell corpses was followed and confocal time-lapse images of ced-6(qx17);smIs34(Pced-1ced-1::gfp) embryos treated with either control (i–v) or mtm-1 RNAi (vi–x) are shown. The time point immediately prior to the appearance of trace amounts of CED-1::GFP adjacent to each cell corpse (arrowed) was set as 0 min. Bars: 5 µm. (B) Quantification of data shown in (A). 34 and 31 cell corpses were followed in control and mtm-1 RNAi-treated embryos, respectively. Numbers in parenthesis indicate the average formation time of the CED-1::GFP ring (±s.e.m). (C) The duration of CED-1::GFP around each cell corpse was followed and confocal time-lapse images of ced-6(qx17);smIs34(Pced-1ced-1::gfp) embryos treated with either control (i–v) or mtm-1 RNAi (vi–x) are shown. The first time point (0 min) was set when a full CED-1::GFP ring (arrowed) was just seen. Bars: 5 µm. (D) Quantification of data shown in (C). 34 and 31 cell corpses were quantified in control and mtm-1 RNAi-treated embryos, respectively. Numbers in parenthesis indicate the average duration time of the CED-1::GFP ring (±s.e.m).doi:10.1371/journal.pgen.1000679.g004
To further prove that mtm-1 RNAi promotes the engulfment of cell corpses, we examined the internalization of apoptotic cells by using a GFP fusion of a cytosolic actin isoform, ACT-5, which clusters around cell corpses during early stages of engulfment and disappears after they are fully engulfed . We found that more cell corpses were labeled by ACT-5::GFP in ced-6(qx17) embryos treated with mtm-1 RNAi than in control animals (Figure 3). A similar increase in the labeling of cell corpses was also observed in ced-6(qx17);mtm-1(RNAi) embryos when two different phagosomal markers, GFP::RAB-7 and LMP-1::GFP, were monitored (Figure 3). RAB-7 associates with phagosomal membranes and controls late steps of phagosome maturation, while LMP-1, a lysosome-associated membrane protein, is recruited to phagosomes during late stages of phagosome maturation –. Therefore, our data suggest that more cell corpses are internalized and enclosed in phagosomes when mtm-1 function is inhibited. As expected, the clustering of both GFP::RAB-7 and LMP-1::GFP around cell corpses was significantly enhanced in ced-1(e1735), ced-6(n2095) and ced-2(n1994) mutants but not ced-5(n1812) mutants after mtm-1 RNAi treatment (Figure S3B, S3C). This supports the hypothesis that mtm-1 negatively regulates cell corpse engulfment through ced-5/12/10.
MTM-1 does not play a similar role in the migration of distal tip cells
Mutations in ced-2, ced-5, ced-12 and ced-10, but not ced-1, ced-6 or ced-7, affect the migration of the two distal tip cells (DTCs), which are located at the tips of the two gonad arms and guide the formation of gonads during larval development ,,,,. In ced-2, ced-5, ced-12 and ced-10 mutants, the DTCs often make extra turns, which causes abnormally shaped gonads ,,. Since mtm-1 negatively regulates cell corpse engulfment through the CED-5/CED-12/CED-10 complex and both MTM-1 and CED-10 are highly expressed in DTCs ( and see below), we tested whether mtm-1 could also modify the DTC migration defect in ced-2, ced-5, ced-12 or ced-10 mutants. We found that mtm-1 RNAi did not obviously affect the DTC migration defect in strong loss-of-function mutants of ced-2, mig-2, ced-5, ced-12 or ced-10, nor did it significantly suppress or enhance the abnormal DTC migration phenotype in ced-2;mig-2 or ced-1;ced-2 double mutants (Table S1). However, we observed that mtm-1 RNAi resulted in a weak DTC migration defect in both wild type and rrf-3(pk1426) mutants (which are hypersensitive to RNAi treatment). Moreover, inactivation of mtm-1 by RNAi significantly enhanced the defect of DTC migration in ced-10(n1993) weak loss-of-function mutants (Table S1). This suggests that mtm-1 may play a positive role in the migration of distal tip cells and may act in the same genetic pathway as ced-10.
Other MTMs do not play redundant roles with MTM-1 in cell corpse engulfment
MTM-1 belongs to the myotubularin family, which constitutes a large group within the tyrosine/dual-specificity phosphatase (PTP/DSP) super-family and which are evolutionarily conserved in yeast, worms and humans  (Figure S4). To examine whether the function of MTM-1 in cell corpse engulfment is conserved, we overexpressed human MTM1 under the control of the C. elegans heat-shock promoters (PhsphMTM1) and found that it efficiently rescued the reduced cell corpse phenotype in mtm-1(ok742);ced-2(n1994) mutants (Table S2). This suggests that human MTM1 can substitute for the function of worm MTM-1 in regulating cell corpse engulfment.
In C. elegans, 5 MTMs have been identified based on sequence homology . Like mammalian MTMs, they may have non-redundant functions. To determine whether other C. elegans MTMs are also involved in cell corpse clearance, we analyzed the cell corpse phenotype of mtm(lf) in the background of ced-1(e1735), which has a cell corpse phenotype that can be attenuated by mtm-1 RNAi. We found that the persistent cell corpse phenotype of ced-1(e1735) mutants was not affected when mtm-9, mtm-6, or mtm-5 was inactivated either individually or in combination (Table S3). Interestingly, when mtm-3 was inactivated by RNAi in ced-1(e1735) mutants, we observed a slight enhancement of cell corpse numbers which was further enhanced by mtm-6(ok330) but not mtm-5(ok469) mutants (Table S3). In wild-type animals, mtm-3 RNAi also caused increased cell corpse numbers, which were significantly enhanced by mtm-6(ok330) but not mtm-5(ok469) mutants (Table S3). This suggests that mtm-3 may play a redundant role with mtm-6 to promote cell corpse clearance or to affect cell death activation. However, since mtm-1 RNAi treatment resulted in an opposite phenotype in ced-1(e1735) mutants, these MTMs appear not to act redundantly with MTM-1 in cell corpse engulfment.
MTM-1 acts as a lipid phosphatase to regulate cell corpse engulfment
Although myotubularins contain CX5R active site motifs characteristic of the protein tyrosine phosphatase super-family, they primarily function as lipid phosphatases to dephosphorylate phosphatidylinositol 3-phosphate (PtdIns(3)P) or phosphatidylinositiol 3, 5-bisphosphate (PtdIns(3,5)P2) ,,. To determine whether MTM-1 acts as a lipid phosphatase to regulate cell corpse engulfment, we generated a catalytically inactive mutant of MTM-1, MTM-1(C378S) . In contrast to overexpression of MTM-1, overexpression of MTM-1(C378S) driven by the C. elegans heat-shock promoters (PhspMTM-1(C378S)) failed to cause accumulation of cell corpses and was unable to rescue the reduced cell corpse phenotype in mtm-1(ok742);ced-2(n1994) double mutants (Figure 1A; Table S2). This indicates that the lipid phosphatase activity of MTM-1 is required for its function in cell corpse engulfment.
Since human MTM1 mainly uses PtdIns(3)P as a substrate both in vitro and in vivo ,,, we next examined whether phosphatidylinositol 3-kinase (PI3K) activity is required for the reduction of cell corpses caused by mtm-1 RNAi. Three classes of phosphatidylinositol 3-kinases (PI3K) are responsible for generating 3-phosphoinositides, among which class I PI3Ks are mainly responsible for generating PtdIns(3,4,5)P3, while the synthesis of PtdIns(3)P in vivo is mostly carried out by class III PI3Ks . In addition, class II PI3Ks produce PtdIns(3)P both in vitro and in vivo ,. C. elegans contains a single homolog of each class: AGE-1, a class I PI3K essential for the C. elegans insulin-like signaling pathway ; VPS-34, a class III PI3K that regulates larval development, endocytosis and cell corpse degradation by generating PtdIns(3)P ,,; and a class II PI3-kinase encoded by the open reading frame F39B1.1 which can compensate for the loss of vps-34 function when mtm-6 is inactivated by RNAi . We found that the deletion mutant ok2346 of the class II PI3-kinase F39B1.1, which we named piki-1 (phosphatidylinositol 3 -kinase), resulted in accumulation of cell corpses at several embryonic stages similar to vps-34(h797), a strong loss-of-function mutant of vps-34 (Figure 5A; Figure S1C). Interestingly, significantly more cell corpses were observed in vps-34(h797);piki-1(ok2346) double mutants than in either single mutant alone (Figure 5A). The increase in cell corpses observed in vps-34(h797);piki-1(ok2346) double mutants is likely due to a defect in apoptotic cell clearance because cell corpses persist on average 1.6 times longer in embryos lacking both vps-34 and piki-1 activities than in wild type (Figure 5B). This indicates that vps-34 and piki-1 act redundantly to regulate the removal of apoptotic cells. In contrast, neither an obvious cell corpse phenotype nor an enhancement of the cell corpse clearance defect was observed when the class I PI3K AGE-1 was inactivated by RNAi in either wild-type animals or vps-34;piki-1 double mutants, indicating that the class I PI3K is not involved in this process (data not shown).
Figure 5. PI3Ks VPS-34 and PIKI-1 are important for cell corpse clearance.
(A) PI3Ks VPS-34 and PIKI-1 act redundantly to remove apoptotic cells. Time-course analysis was performed in wild type (black), vps-34 (h797) (gray), piki-1(ok2346) (light gray), and vps-34(h797);piki-1(ok2346) double mutants (hatching). Cell corpses were scored and analyzed as described in Figure 1. Data from wild type and mutant animals were compared as described in Figure 1. **P<0.0001; all other points had P value>0.05. (B) Four-dimensional microscopy analysis of cell corpse duration in vps-34(h797);piki-1(ok2346) mutants. The durations of 30 cell corpses from wild type (n = 3; black bars) and 34 cell corpses from vps-34(h797);piki-1(ok2346) double mutants (n = 3; gray bars) were monitored as described in Figure 2 and Materials and Methods. The numbers in parenthesis indicate the average duration of cell corpses (±s.e.m).doi:10.1371/journal.pgen.1000679.g005
We next examined whether mtm-1 RNAi is able to reduce cell corpse numbers in ced-1(e1735) mutants when PI3K activity is blocked. Although a reduction in cell corpses was still observed in vps-34(h797)ced-1(e1735) or ced-1(e1735);piki-1(ok2346) double mutants treated with mtm-1 RNAi, no obvious difference in the number of cell corpses was seen in vps-34ced-1;piki-1 triple mutants after mtm-1 RNAi treatment (Table 2). This indicates that the reduction of cell corpses in ced-1(e1735) mutants by mtm-1 RNAi requires the activity of both class III and class II PI3Ks. Similar effects were also observed when mtm-1 was inactivated in vps-34;piki-1 double mutants or in ced-6 or ced-7 mutants lacking both vps-34 and piki-1 functions (Table 2). Therefore, MTM-1 may coordinate with the PI3Ks VPS-34 and PIKI-1 to regulate the level of PtdIns(3)P for cell corpse engulfment.
Table 2. vps-34 and piki-1 are required for the reduction in cell corpses by mtm-1 RNAi.doi:10.1371/journal.pgen.1000679.t002
MTM-1 functions in engulfing cells and localizes to the plasma membrane
To determine the subcellular localization of MTM-1, we generated a MTM-1::GFP fusion driven by the mtm-1 promoter (Pmtm-1mtm-1::gfp), which fully rescued the cell corpse phenotype of mtm-1(ok742);ced-2(n1994) mutants (Table S2). The expression of MTM-1::GFP was seen from embryogenesis throughout larval and adult stages in many known engulfing cell types including hypodermal cells, body wall muscle cells, pharyngeal muscle cells and sheath cells (Figure 6A). MTM-1::GFP was also observed in vulva cells, distal tip cells and coelomocytes, which is consistent with previous findings that mtm-1 RNAi rescues the coelomocyte uptake defect in vps-34(lf) mutants (Figure S5A) . In agreement with this expression pattern, we found that overexpression of MTM-1 controlled by the ced-1 promoter (Pced-1mtm-1), which drives gene expression specifically in engulfing cells, fully rescued the reduced cell corpse phenotype in mtm-1(ok742);ced-2(n1994) mutants. This rescuing activity was not observed when MTM-1 expression was controlled by the egl-1 promoter (Pegl-1mtm-1), which drives gene expression specifically in dying cells (Table S2) ,. This indicates that mtm-1 needs to function in engulfing cells to regulate cell corpse engulfment.
Figure 6. MTM-1 is expressed in engulfing cells and localizes to the plasma membrane.
DIC and fluorescent confocal images of wild-type animals carrying an integrated array of Pmtm-1MTM-1::GFP are shown. MTM-1 is expressed in several known engulfing cell types including pharyngeal muscle cells (i, ii), hypodermal cells (iii, iv), body wall muscle cells (v, vi) and sheath cells (vii, viii) as indicated by arrows and is mainly localized to cell membranes. MTM-1::GFP also clusters around apoptotic cells (ix, x). Bars: 10 µm. (B) DIC (i), GFP (ii), mCHERRY (iii) images and the merged image of GFP and mCHERRY (iv) of a wild-type embryo co-expressing MTM-1::GFP driven by mtm-1 promoter (Pmtm-1mtm-1::gfp) and myri::mCHERRY controlled by heat-shock promoters (Phspmyri::mcherry) are shown. MTM-1::GFP co-localized with myri::mCHERRY to plasma membranes. Bars: 5 µm. (C) The PH-GRAM and PTP domains of MTM-1 are required for membrane localization of MTM-1. DIC and fluorescent confocal images of full-length (i, ii) and truncated GFP::MTM-1 (iii–viii) controlled by the ced-1 promoter in wild-type embryos are shown. Membrane localization was clearly seen with full-length MTM-1 (i, ii) and MTM-1(ΔCC) (vii, viii), but not in embryos expressing GFP::MTM-1 lacking either the PTP domain (iii, iv) or the PH-GRAM domain (v, vi). Bars: 5 µm.doi:10.1371/journal.pgen.1000679.g006
We found that MTM-1::GFP is mainly localized to the plasma membrane and coincides with myri::mCHERRY, which specifically labels cell membranes (Figure 6; personal communication with Dr. David Sherwood and Dr. Guangshuo Ou; Materials and Methods). GFP::MTM-1 expressed from engulfing cells (Pced-1gfp::mtm-1) also localizes to plasma membranes and overlaps with CED-1::mCHERRY, a cell surface phagocytic receptor (Figure 7A) . Interestingly, we found that GFP::MTM-1 and CED-1::mCHERRY not only co-localized to the plasma membrane, but clustered around the same apoptotic cell, suggesting that MTM-1 may associate with extending pseudopods or nascent phagosomes at a similar stage to CED-1 (Figure 7A). Indeed, by time-lapse analysis, we observed that GFP::MTM-1 and CED-1::mCHERRY appeared on the surface of dying cells simultaneously during the early stage of engulfment (Figure 7B). However, GFP::MTM-1 disappeared more quickly than CED-1::mCHERRY from the phagosome after internalization, suggesting that MTM-1 only transiently associates with apoptotic cells during engulfment (Figure 7B).
Figure 7. MTM-1 and CED-1 co-localize to apoptotic cells.
(A) DIC and fluorescence images of a wild-type embryo expressing both GFP::MTM-1 and CED-1::mCHERRY controlled by the ced-1 promoter are shown. MTM-1 and CED-1 co-localize to the plasma membrane (i–iv) and are clustered around the same apoptotic cell (arrow) internalized by the neighboring engulfing cell (arrowhead) (v–viii). Bars: 5 µm. (B) MTM-1 transiently associates with the apoptotic cell during engulfment. Confocal time-lapse images of a wild-type embryo co-expressing Pced-1gfp::mtm-1 (i–v) and Pced-1ced-1::mcherry (vi–x) are shown. The apoptotic cell followed is indicated by the arrow and the time point immediately prior to the appearance of GFP::MTM-1 or CED-1::mCHERRY was set as 0 min. The longer duration of the apoptotic cell is likely caused by overexpression of GFP::MTM-1. Bars: 5 µm.doi:10.1371/journal.pgen.1000679.g007
Similar to the mammalian MTM1 protein, C. elegans MTM-1 contains several conserved motifs including an N-terminal PH-GRAM domain which may have the capacity to bind phosphoinositides, a central myotubularin-related domain, a protein tyrosine phosphatase domain (PTP) that contains the catalytic activity, and a C-terminal coiled-coil domain (CC) which might be involved in protein-protein interactions  (Figure S4). To find out which domain is important for the membrane localization of MTM-1, we generated several truncated GFP::MTM-1 fusions driven by the ced-1 promoter and examined their localizations. All of the MTM-1 truncations were expressed at the expected size in C. elegans (Figure S5B). We found that MTM-1 lacking either the PH-GRAM domain (GFP::MTM-1(ΔGRAM)) or the PTP domain (GFP::MTM-1(ΔPTP)) completely lost its membrane localization and instead displayed a punctate vesicular localization pattern. This indicates that both the PH-GRAM and PTP domains are required for the plasma membrane localization of MTM-1 (Figure 6C). In contrast, GFP::MTM-1(ΔCC), in which the C-terminal coiled-coil motif is deleted, still localized to the plasma membrane (Figure 6C). Moreover, we found that this membrane-localized GFP::MTM-1(ΔCC) was able to rescue the reduced cell corpse phenotype of mtm-1(ok742);ced-2(n1994) mutants, suggesting that the coiled-coil motif is dispensable for MTM-1 function in cell corpse engulfment (Table S2). Conversely, neither ΔPH-GRAM nor ΔPTP truncations could rescue the cell corpse phenotype of mtm-1 deletion mutants (Table S2).
Since the PH-GRAM domain likely mediates the binding of myotubularins to phosphoinositides, and the PTP domain contains catalytic activity, we further determined whether PtdIns(3)P is required for locating MTM-1 to the cell membrane by examining the MTM-1::GFP expression pattern in vps-34(lf) mutants in which the production of PtdIns(3)P is largely blocked . We found that the plasma membrane localization of MTM-1 was not obviously affected in vps-34(h797) mutants (Figure S5C). Moreover, no significant difference in the localization of MTM-1::GFP was observed in either piki-1(ok2346) mutants or vps-34(h797);piki-1(ok2346) double mutants (Figure S5C). Therefore, neither PI3Ks nor substrates of MTM-1 seem to be required for its plasma membrane localization.
Inactivation of MTM-1 increases the accumulation of PtdIns(3)P on intracellular vesicles
Because MTM-1 is a lipid phosphatase, its negative role in cell corpse engulfment might be achieved by regulating the level of PtdIns(3)P. To test this hypothesis and assess whether mtm-1 can negatively regulate PtdIns(3)P levels in C. elegans, we monitored the localization and accumulation of PtdIns(3)P in both wild type and mtm-1(ok742) mutants using a YFP::2xFYVE probe which specifically binds PtdIns(3)P on both endosomes and phagosomes ,. Compared to wild-type animals, there were significantly more YFP::2xFYVE-positive vesicles in mtm-1(ok742) larvae, and the number of positive vesicles was greatly reduced when vps-34 activity was inhibited (Figure 8A). This indicates that MTM-1 may modulate the level of PtdIns(3)P on intracellular vesicles. We then quantified YFP::2xFYVE labeling in hypodermal cells which highly express MTM-1 and can act as engulfing cells. In wild-type animals, we observed an average of 79 YFP::2xFYVE-positive vesicles, which was significantly reduced to 27 by treatment with vps-34 RNAi (Figure 8B). This indicates that vps-34 is responsible for generating PtdIns(3)P on these vesicles. In contrast, over 66% of mtm-1(ok742) worms contained more than 110 vesicles positive for YFP::2xFYVE. The average number of YFP-2xFYVE-positive vesicles in mtm-1(ok742) animals was 128, which is 62% more than in wild type, suggesting that MTM-1 negatively regulates the vesicular accumulation of PtdIns(3)P (Figure 8B).
Figure 8. MTM-1 negatively regulates the level of PtdIns(3)P on intracellular vesicles.
(A) The localization and accumulation of PtdIns(3)P were examined in hypodermal cells using a YFP::2xFYVE probe. mtm-1(ok742) larvae (v, vi) contained significantly higher numbers of YFP-positive vesicles than wild type (i, ii), whereas inactivation of PI3K VPS-34 by RNAi greatly reduced the PtdIns(3)P level in both wild type (iii, iv) and mtm-1(ok742) mutants (vii, viii). Images were captured using a fixed exposure time of 550 ms for wild type and mtm-1(ok742) mutants and 1500 ms for animals treated with vps-34 RNAi. Bars: 5 µm (B) Quantification of data shown in (A). 30 L2 larvae from each strain were quantified as described in Materials and Methods. The y-axis shows the number of animals that contain YFP::2xFYVE-positive vesicles within a specific range as shown on the x-axis. The numbers in parenthesis indicate the average number of vesicles positive for YFP::2xFYVE (±s.e.m).doi:10.1371/journal.pgen.1000679.g008
Why is a negative regulation of engulfment required?
The rapid and efficient phagocytosis of apoptotic cells is crucial for maintaining homeostasis as well as regulating the immune responses. Therefore, it seems to be counterintuitive to think that engulfment needs to be down-regulated. In fact, phagocytosis of apoptotic cell not only clears dead cells but promotes cell killing. For example, macrophages taking up apoptotic cells will release FasL and promote Fas-mediated apoptosis of monocytes and neutrophils for quick resolution of inflammation . It has also been reported that macrophages are involved in tissue remodeling by promoting apoptosis in vertebrates –. Furthermore, genetic studies in C. elegans showed that blocking engulfment enhances the survival of cells triggered to initiate programmed cell death ,. Hence, it is conceivable that uncontrolled engulfment may lead to unexpected cell deaths under certain circumstances and an inhibitory mechanism may protect cells from inappropriate death. In addition, negative regulation of engulfment may also contribute to the correct targeting of apoptotic cells by phagocytes. In contrast to apoptotic cells that expose “eat me” flags on the surface, living cells exhibit “don't eat me” signals, such as CD47 and CD31, in order to be discriminated from dead cells ,. Although intracellular pathways transducing this type of signal have not been identified, it is possible that negative regulators are involved in mediating “don't eat me” signals within engulfing cells and in inhibiting the engulfment of normal healthy cells.
MTM-1 negatively regulates cell corpse engulfment through CED-5/12/10
Although many genes are known be involved in apoptotic cell clearance, very few of them play a negative role. In mammalian macrophages, the small GTPase RhoA and its effector Rho-kinase were shown to negatively regulate the engulfment of apoptotic cells ,. Recently, C. elegans ABL-1 kinase was reported to inhibit cell corpse engulfment and DTC migration through its interacting protein ABI-1 . However, the underlying mechanisms whereby these genes negatively regulate engulfment are not clear.
In order to gain more insight into the negative regulation of phagocytosis, we performed an RNAi screen to search for negative regulators of cell corpse engulfment and identified C. elegans myotubularin MTM-1, which was previously reported to play a role in endocytosis. Our genetic and cell biological analyses indicate that inactivation of MTM-1 promotes cell corpse engulfment, while overexpression of MTM-1 results in accumulation of cell corpses, suggesting that MTM-1 negatively regulates the engulfment of apoptotic cells. Given that inactivation of mtm-1 reduced the number of cell corpses in strong loss-of-function mutants of ced-1, ced-6, ced-7 and ced-2 but not ced-5, ced-12 or ced-10, mtm-1 likely functions through the CED-5/CED-12/CED-10 complex. We still observed a significant reduction in cell corpses when mtm-1 was inhibited in ced-2(n1994);mig-2(mu28) double mutants, which suggests that MIG-2 and CED-2 do not mediate all the inputs into the CED-10 pathway and an additional branch may exist in parallel to both of them. Since overexpression of MTM-1 failed to enhance the engulfment phenotype in ced-2, ced-5, ced-12 or ced-10 mutants, we prefer a model in which mtm-1 functions downstream of mig-2 and ced-2 to negatively regulate the CED-5/CED-12/CED-10 complex rather than a model where mtm-1 acts in a parallel pathway which requires CED-10 function for engulfment. Recently, ABL-1 kinase was reported to inhibit both cell corpse engulfment and DTC migration by acting in a parallel pathway to the two known engulfment pathways. Moreover, the functions of CED-5, CED-12 and CED-10 were required for its inhibition of engulfment but not DTC migration . As both ABL-1 and MTM-1 negatively regulate cell corpse engulfment through CED-5, CED-12 and CED-10, it will be interesting to test the genetic interaction between them.
MTMs play non-redundant roles in the engulfment of apoptotic cells
In C. elegans, 5 MTMs (MTM-1, 3, 6, 9 and 5) have been identified based on sequence homology. They belong to 5 different subgroups with mtm-5 and mtm-9 encoding catalytically inactive phosphatases and probably perform non-redundant functions like mammalian MTMs . In agreement with this notion, we found that MTM-1, but not other MTMs, plays a negative role in cell corpse engulfment. Interestingly, mtm-3(lf);mtm-6(lf) double mutants contain significantly higher numbers of cell corpses than wild type and they also enhance the cell corpse phenotype of ced-1(e1735) mutants, suggesting that mtm-3 and mtm-6 may play a redundant role to either promote cell corpse clearance or affect cell death activation. Since mtm-6 has only been implicated in regulating an ARF-6- and RME-1-dependent endocytic pathway together with mtm-9, whereas the functions of mtm-3 are mostly unknown, it will be important to determine whether these MTMs are directly involved in cell death processes and if so, which specific steps they regulate and how their activities are coordinated.
MTM-1 may down-regulate cell corpse engulfment by modulating plasma membrane PtdIns(3)P levels
Myotubularins are lipid phosphatases that specifically dephosphorylate PtdIns(3)P or its metabolite PtdIns(3,5)P2 . Our findings that MTM-1 acts as a negative regulator of cell corpse engulfment dependent on its lipid phosphatase activity suggest that 3-phosphoinositides may act as signaling molecules during engulfment. Given that both the class III PI3K vps-34 and the class II PI3K piki-1 are required for reducing cell corpses by mtm-1 RNAi and that loss of mtm-1 function increases the vesicular accumulation of PtdIns(3)P in vivo, PtdIns(3)P likely serves as a substrate of MTM-1 during engulfment. Although PtdIns(3)P is enriched in endocytic compartments , we found that MTM-1 is mainly localized to plasma membrane. Although both the phosphoinositide-binding domain PH-GRAM and the catalytic domain PTP are required for membrane association of MTM-1, PtdIns(3)P seems to be dispensable for its membrane localization because MTM-1 still localizes to the plasma membrane in vps-34(lf), piki-1(lf) or vps-34(lf);piki-1(lf) double mutants, in which PtdIns(3)P generation is probably blocked . This observation also excludes the possibility that MTM-1 is recruited to plasma membranes through direct interaction with VPS-34 or PIKI-1. Therefore, MTM-1 may associate with plasma membranes through its interactions with other phosphinositides or protein partners such as VPS34 adaptor protein which binds hMTM1 on endosomes . Consistent with our observations, several human MTMs were also reported to localize to plasma membranes although their substrates PtdIns(3)P and PtdIns(3,5)P2 are concentrated on early and late endocytic compartments, respectively, which leads to the hypothesis that myotubularins may act to prevent accumulation of PtdIns(3)P or PtdIns(3,5)P2 at inappropriate compartments ,. In the case of MTM-1, it is possible that MTM-1 coordinates with PI3Ks VPS-34 and PIKI-1 to maintain an appropriate level of PtdIns(3)P on the plasma membrane for the internalization of cell corpses. In agreement with this hypothesis, we found that MTM-1 transiently associates with extending pseduopods and nascent phagosomes at a similar stage to the phagocytic receptor CED-1 during engulfment.
Although PtdIns(3)P is a proven critical regulator of early endosomal traffic and phagosome maturation, its involvement in cell corpse engulfment has not been reported. We propose that PtdIns(3)P acts as a positive signal for engulfment based on our findings that (i) mtm-1 antagonizes cell corpse internalization, which requires both its lipid phosphatase activity and the functions of PI3Ks VPS-34 and PIKI-1, (ii) MTM-1 localizes to the plasma membrane, functions in engulfing cells and clusters around cell corpses during engulfment, and (iii) MTM-1 negatively regulates the vesicular accumulation of PtdIns(3)P in vivo. Interestingly, DOCK180, the mammalian homolog of CED-5, binds directly to PtdIns(3,4,5)P3 through its DHR1 domain in vitro and translocates to the cell membrane in response to PtdIns(3,4,5)P3 production in NIH3T3 cells . Since the Class I PI3K AGE-1 which generates PtdIns(3,4,5)P3 appears not to be required for cell corpse engulfment in C. elegans, it is possible that CED-5/CED-12 GEF is recruited to the plasma membrane by PtdIns(3)P to activate CED-10/Rac, and that MTM-1 acts antagonistically to terminate the signal and release the complex after engulfment. Alternatively, PtdIns(3)P may bind and facilitate the nucleotide exchange of CED-10/Rac during engulfment, similar to the way in which PtdIns(4,5)P2 promotes Rho and Rac activation under certain conditions .
The function of MTM-1 in cell corpse engulfment may be conserved from C. elegans to mammals
Myotubularin family phosphatases are conserved amongst all eukaryotic organisms, but their cellular functions are not well understood. Our finding that overexpression of human MTM1 can efficiently rescue the cell corpse phenotype of mtm-1(lf) mutants suggests that the role of MTM-1 in cell corpse engulfment is likely conserved from worms to humans and that similar mechanisms may also be used in mammals to regulate the removal of apoptotic cells.
We found that MTM-1 acts as a lipid phosphatase to negatively regulate the engulfment of apoptotic cells through CED-10/Rac, which raises the interesting question of whether MTM-1 is similarly involved in other CED-10/Rac-mediated cellular processes by regulating PtdIns(3)P. Intriguingly, we found that mtm-1 seems to play a positive instead of a negative role in the migration of DTCs, a process which also requires the activity of CED-5, CED-12 and CED-10. MTM-1 may therefore play distinct roles in different CED-10/Rac-mediated processes. However, we currently do not know whether the function of MTM-1 in DTC migration is also mediated by PtdIns(3)P and, if so, whether the opposite roles of MTM-1 in cell corpse engulfment and DTC migration are caused by distinct effects of PtdIns(3)P on CED-10/Rac in these two processes. On the other hand, loss of myotubularin has been found to cause muscle defects in human, mouse and zebrafish ,,, but the underlying mechanism is not understood. Since we have identified a genetic link between MTM-1 and CED-10/Rac in cell corpse engulfment, it will be interesting to test whether misregulation of Rac GTPase might be relevant to the muscle defect caused by lack of myotubularin.
Materials and Methods
C. elegans strains
Strains of C. elegans were cultured at 20°C using standard procedures . The N2 Bristol strain was used as the wild-type strain. Mutations used are described in C. elegans II  unless otherwise indicated. Linkage group I (LGI): ced-1(e1735), vps-34(h797), dpy-5(e61), unc-13(e450am), mtm-1(ok742) (this study), ced-12(n3261) , hT2(bli-4(e937);let-?(q782)qIs48/sep-1(e2406) (Wormbase:www.wormbase.org). LGII: rrf-3(pk1426) . LGIII: ced-6(n2095), ced-6(qx17) (this study and see below), ced-7(n2094), mtm-6(ok330) (this study, Wormbase: www.wormbase.org). LGIV: ced-2(n1994), ced-5(n1812), ced-10(n3246), ced-10(n1993). LGX: mig-2(mu28) , piki-1(ok2346) and mtm-5(ok469) (this study, Wormbase: www.wormbase.org). smIs34 (Pced-1ced-1::gfp) and smIs95 (Phspannexin v::mrfp) were provided by Dr. Ding Xue (University of Colorado, CO). opIs334 (Pced-1YFP::2xFYVE) was a gift from Dr. K. S. Ravichandran (Univ. of Virginia, Charlottesville, VA) and Dr. M. O. Hengartner (Univ. of Zurich, Zurich, Switzerland) .
Other strains carrying integrated arrays used in this study are listed below:
qxIs156 (PhspMTM-1), qxIs210 (PhspMTM-1(C378S)), qxIs197 (Pmtm-1MTM-1::GFP), qxIs66 (Pced-1GFP::RAB-7), qxIs40 (Pced-1ACT-5::GFP), qxIs60 (Pced-1LMP-1::GFP). The vps-34-deficient strain, vps-34(h797), is maintained as dpy-5(e61)vps-34(h797); qxEx [vps-34(+); Psur-5sur-5::gfp]. Non-green embryos (dpy-5(e61)vps-34(h797)) were scored as vps-34(lf) and green embryos that carry the vps-34(+) transgene were scored as wild type for vps-34.
qx17 is a recessive mutation isolated from a forward genetic screen for additional regulators of cell corpse engulfment and was mapped to linkage group III very close to ced-6. A complementation test between qx17 and ced-6(n2095) was performed and a similar engulfment phenotype was observed in the double heterozygote, indicating that qx17 is an allele of ced-6. We determined the sequence of ced-6 in qx17 mutants and identified a T to A transition that results in a premature stop codon after Glu 475 and generates a truncated CED-6 protein lacking the last 17 amino acids at the C-terminus.
Quantification of cell corpses, cell death events, and cell corpse duration
Somatic cell corpses were directly visualized by differential interference contrast (DIC) microscopy as highly refractile button-like objects distinct from normal living cells ,. C. elegans embryos were mounted on agar pads in M9 and viewed using a 100× Plan-Neofluar DIC objective on an Axioimager M1 microscope (Carl Zeiss, Inc.). The number of cell corpses was quantified in the head region of living embryos either at the six different embryonic stages (bean/comma, 1.5-fold, 2-fold, 2.5-fold, 3-fold and 4-fold) for a time-course analysis or at the 4-fold embryonic stage as described before . To measure the duration of cell corpses, four-dimensional microscopy (4D) analysis was performed at 20°C as described before with some modifications for vps-34(h797);piki-1(ok2346) mutants . Since vps-34(lf) causes embryonic lethality and most vps-34(h797) mutant embryos die before the 4-fold embryonic stage, it is maintained as dpy-5(e61)vps-34(h797); qxEx [vps-34(+); Psur-5sur-5::gfp]. To monitor the cell corpse duration in vps-34(h797);piki-1(ok2346) mutants, only non-green embryos which developed normally until the 2.5- or 3-fold stage were followed and quantified. To examine the internalization of cell corpses, apoptotic cells were first identified by their refractile disk-like morphology using Nomarski DIC microscopy and then different fluorescent markers that associate with cell corpses at different stages of engulfment were examined. To monitor the occurrence of embryonic cell death, embryos at the 2–4 cell stage were mounted on agar pads and images in a 30 µm z series (0.75 µm/section) were captured every 1.5 minutes for 8 h using a Zeiss Axioimager M1 microscope (Carl Zeiss, Inc.). Images were processed and viewed using Axiovision Rel 4.5 software (Carl Zeiss, Inc.).
RNAi and genome-wide RNAi screen
The genome-wide RNAi screen was performed as described before with some modifications . Briefly, adult hermaphrodites of ced-1(e1735);rrf-3(pk1426) were bleached on NGM plates without OP50. The hatched larvae were washed off with M9 and added to individual RNAi plates with 30 larvae per plate (C. elegans RNAi library, Geneservice, UK). Cell corpses were scored in the progeny at the 4-fold embryonic stage. For mtm-1 RNAi by feeding, gravid adults of the indicated strains (P0) were picked and bleached on either control (pPD129.36-gfp or pPD129.36 for examining MTM-1::GFP expression) or mtm-1 RNAi plates (I-6C09) and the number of embryonic cell corpses or the expression of MTM-1::GFP was scored in the F2 generation. To quantify the DTC migration defect, L4 larvae of the F2 generation were aged 24 h before examination. mtm-1 RNAi caused 14% and 40% embryonic lethality in wild type and the RNAi hypersensitive mutant rrf-3(pk1426), respectively, while 7% of wild-type and 29% of rrf-3(pk1426) embryos died when treated with gfp RNAi. For mtm-1 RNAi by injection, a double-stranded RNA (dsRNA) of mtm-1 (436–2489 bp of Y110A7A.5) was synthesized in vitro and injected into ced-1(e1735);qxIs197 animals, which carry an integrated array of MTM-1::GFP controlled by the mtm-1 promoter (Pmtm-1MTM-1::GFP). Embryonic cell corpses and expression of MTM-1::GFP were both examined 24 h post injection. For mtm-3 and mtm-9 RNAi, double-stranded RNAs (dsRNA) were synthesized (mtm-3: 5812–6435 bp of T24A11.1a; mtm-9: 1583–2031 bp of Y39J10A.3a) and injected individually or in combination. Embryonic cell corpses were quantified 24 h post injection.
Young adults were moved to fresh nematode growth medium (NGM) plates and cultured at 20°C for 12 h before they were incubated at 33°C for 1 h (+HS) or left at 20°C without heat-shock treatment (−HS), followed by recovery at 20°C for 1.5 h. Adult worms were removed and embryos were incubated at 20°C and scored for the number of cell corpses 5 to 10 h after treatment.
A Zeiss LSM 510 Pascal inverted confocal microscope with 488, 514, 633 lasers (Carl Zeiss Inc.) was used to capture fluorescent images which were processed and viewed using LSM Image Browser software. Time-lapse imaging of CED-1::GFP, GFP::MTM-1 and CED-1::mCHERRY was performed as described . Briefly, C. elegans embryos at the pre-comma or comma stage were mounted on agar pads and images in a 20–25 z series (1.0 µm/section) were captured every 1 min, 1.5 min or 2 min for 120 min using a Zeiss LSM 510 Pascal inverted confocal microscope (Carl Zeiss, Inc.). Images were processed and viewed using LSM Image Browser software.
Examination of PtdIns(3)P level by YFP::2xFYVE probe
To examine the level of PtdIns(3)P using the YFP::2xFYVE probe, L2 larvae of wild type, surviving mtm-1(ok742) mutants derived from hT2/mtm-1(ok742) worms, and vps-34 RNAi-treated wild type or mtm-1(ok742) mutants were mounted on agar pads. Nomarski and fluorescent images of the midbody region of L2 larvae in a 20 z series (1.0 µm/section) were captured using a fixed exposure time with a Zeiss Axioimager A1 equipped with epifluorescence and an Axiocam monochrome digital camera. The exposure time was 550 ms for wild type and mtm-1(ok742) mutants, but 1500 ms for animals treated with vps-34 RNAi because only very faint YFP::2xFYVE signal can be observed at 550 ms in these worms due to significant reduction of PtdIns(3)P accumulation caused by loss of vps-34 function. Serial optical sections were analyzed and the numbers of YFP::2xFYVE-positive vesicles were quantified in hypodermal cells in a region of approximately 88 µm×18 µm. At least 30 animals were quantified in each strain.
PCR primer sequences are shown in Table S4. To generate Pmtm-1mtm-1::gfp , a 3.9 kb genomic fragment of mtm-1 including a 0.8 kb promoter region was amplified by PCR from WRM0617dG02 using primers PQL121/120 and cloned into the pPD95.77 vector through its Bam HI and Sma I sites. A 3.1 kb fragment containing the full-length genomic sequence of the mtm-1 gene was PCR-amplified from WRM0617dG02 using primers PWDL108/109 and cloned into both pPD49.78 and pPD49.83 through the Nhe I-Kpn I sites to generate Phspmtm-1. The same mtm-1 genomic fragment was also amplified by primers PWZ215/PWDL109 and cloned into Pced-1gfp vector through the Kpn I site to generate Pced-1gfp::mtm-1. The C378S mutation was introduced into pPD49.83-mtm-1 by site-directed mutagenesis using primers PQL148/149 (QuickChange; Stratagene, USA) and re-cloned into both pPD49.78 and pPD49.83 via their Nhe I and Kpn I sites. To construct Pced-1mtm-1 and Pegl-1mtm-1, the full-length cDNA of mtm-1 was amplified from a C. elegans cDNA library (Invitrogen, USA) by PWZ215/PWDL109 and cloned into both Pced-1 and Pegl-1 vector through the Kpn I site. To generate Pced-1GFP::MTM-1(ΔGRAM), Pced-1GFP::MTM-1(ΔPTP) and Pced-1GFP::MTM-1(Δcoiled-coil), a 2.1 kb genomic fragment of mtm-1 (ΔGRAM: 975–3072 bp) or a 1.7 kb mtm-1 genomic sequence (1–1739 bp) (ΔPTP) or a 3 kb mtm-1 fragment (Δcoiled-coil: 1–3000 bp) were PCR-amplified from WRM0617dG02 using primers PWZ291/PWDL109, PWZ215/PWZ151 and PWZ215/PWZ322, respectively, and cloned into the Pced-1gfp vector via its Kpn I site. To construct PhsphMTM1, the full-length cDNA of human MTM1 was amplified from a human cDNA library (Clontech, USA ) with primers PWZ384/385 and cloned into both pPD48.78 and pPD49.83 through the Nhe I-Kpn I sites. To generate Phspmyri::mcherry, mcherry was amplified from pAA65  using primers PWZ421 (which contains a myristoylation signal) and PWZ427 and cloned into both pPD49.78 and pPD49.83 through the Kpn I site.
mtm-1 RNAi treatments specifically inhibit the expression of mtm-1. (A) mtm-1 RNAi treatments (either feeding with bacteria expressing mtm-1 dsRNA or injecting in vitro-synthesized mtm-1 dsRNA) result in reduction of cell corpse numbers and inhibition of MTM-1::GFP expression. RNAi experiments were performed as described in Materials and Methods. Cell corpses were scored at the 4-fold embryonic stage and are shown as mean±s.e.m. At least 15 embryos were scored for cell corpses and 40 embryos at the 4-fold embryonic stage were examined for expression of MTM-1::GFP. Representative pictures of MTM-1::GFP expression before and after mtm-1 RNAi treatment are also shown. The exposure time of both pictures was 2000 ms. (B,C) The gene structures of mtm-1 and piki-1 are shown, with filled boxes representing the exons and thin lines indicating the introns. The arrows show the direction of the transcript. The gray bars below the genes indicate the position and size of the deletions in the ok742 and ok2346 mutant.
(1.05 MB TIF)
mtm-1 RNAi accelerates internalization of the apoptotic cell C3. (A) DIC and fluorescence images of a wild-type embryo co-expressing CED-1::GFP (Pced-1ced-1::gfp) and a secreted Annexin V::mRFP under the control of heat-shock promoters (Phspannexin v::mrfp) are shown. The apoptotic cell C3 (white arrow) and a posterior apoptotic cell (blue arrow) were labeled by both CED-1::GFP and Annexin V::mRFP. The ventral hypodermal cell that engulfs C3 is indicated by the arrowhead. Bars: 5 µm. (B,C) The formation and duration of the CED-1::GFP ring around C3 (arrowed) were followed in ced-6(qx17) mutants treated with either control (i–iv in B and i–v in C) or mtm-1 RNAi (v–viii in B and vi–x in C). To monitor the formation of CED-1 rings, the “0 min” time point was set immediately prior to the appearance of trace amounts of CED-1::GFP around C3. To monitoring the duration of CED-1 rings, the “0 min” time point was set when a full CED-1::GFP ring was just visible. 13 C3 corpses were monitored and quantified for either formation or duration of CED-1::GFP rings (ix in B and xi in C). The numbers in parenthesis indicate average formation or duration times of CED-1::GFP rings (±s.e.m). Bars: 5 µm.
(2.95 MB TIF)
Inactivation of MTM-1 promotes cell corpse internalization. Clustering of CED-1::GFP around cell corpses (A) or the phagosomal association of GFP::RAB-7 (B) and LMP-1::GFP (C) was quantified in 1.5-fold stage embryos in the indicated strains. At least 15 embryos were scored in each strain. Error bars indicate s.e.m. Unpaired t tests were performed to compare the data derived from mtm-1 RNAi-treated embryos with that from control animals. **P<0.0001, *P<0.01; all other points had P value>0.01.
(0.13 MB TIF)
Myotubularin is conserved in yeast, worms and humans. Protein sequence alignments of C. elegans MTM-1 (c.eMTM-1), human myotubularin (hMTM1) and yeast myotubularin (Ymr1p) are shown. Identical residues are in black and similar ones are in gray. Conserved motifs are boxed. The signature CX5R active site motif for the protein tyrosine phosphatase super-family is circled in red. The critical cysteine residue, which is changed to serine in the C. elegans MTM-1(C378S) mutant, is marked by a red arrowhead.
(0.50 MB TIF)
Plasma membrane localization of MTM-1 does not require the activities of PI3-kinases. (A) MTM-1::GFP is expressed in many different cell types. DIC and fluorescence images of wild-type animals expressing Pmtm-1mtm-1::gfp are shown. MTM-1::GFP was seen in distal tip cells (i, ii), coelomocytes (iii, iv) and vulva cells (v, vi). Bars: 10 µm. (B) Both full-length and truncated GFP::MTM-1 were stably expressed in C. elegans. Lysates were prepared from 200 adult transgenic worms carrying Pced-1GFP::MTM-1, Pced-1GFP::MTM-1(δGRAM), Pced-1GFP::MTM-1(δPTP) or Pced-1GFP::MTM-1(δCC) and western blot analysis was performed using an anti-GFP antibody. Full-length GFP::MTM-1 (93 Kd) and the three GFP::MTM-1 truncations (δCC: 91 Kd, δGRAM: 76 Kd, δPTP: 65 Kd) were all expressed at the expected size. (C) DIC and fluorescence images of MTM-1::GFP in wild-type (i, ii), vps-34(h797) (iii, iv), piki-1(ok2346) (v, vi) and vps-34(h797);piki-1(ok2346) (vii, viii) embryos are shown. The plasma membrane localization of MTM-1::GFP is not affected in the loss-of-function mutants of PI3-kinases. Bars: 5 µm.
(2.85 MB TIF)
Inactivation of MTM-1 affects the migration of DTCs.
(0.04 MB DOC)
The lipid phosphatase activity and conserved domains of MTM-1 are important for its function in cell corpse engulfment.
(0.04 MB DOC)
Other MTMs do not play redundant roles with MTM-1 in cell corpse engulfment.
(0.04 MB DOC)
Primers used for plasmid construction.
(0.04 MB DOC)
The clustering of CED-1::GFP in a ced-6(qx17) embryo treated with mtm-1 RNAi. The formation of a CED-1::GFP ring around a dying cell in a mtm-1 RNAi-treated ced-6(qx17) embryo is shown. The cell corpse followed is indicated by an arrow. The frames were collected every 1 min and displayed every 1 sec. Selected images are shown in Figure 4A.
(0.35 MB AVI)
The clustering of CED-1::GFP in a ced-6(qx17) embryo treated with control RNAi.The formation of a CED-1::GFP ring around a dying cell in a control RNAi-treated ced-6(qx17) embryo is shown. The cell corpse followed is indicated by an arrow. The frames were collected every 1.5 min and displayed every 1 sec. Selected images are shown in Figure 4A.
(0.33 MB AVI)
The duration of CED-1::GFP around dying cell in a ced-6(qx17) embryo treated with control RNAi.The duration of the CED-1::GFP ring around a cell corpse in a control RNAi-treated ced-6(qx17) embryo is shown. The cell corpse followed is indicated by an arrow. The frames were collected every 1 min and displayed every 1 sec. Selected images are shown in Figure 4C.
(0.81 MB AVI)
The duration of CED-1::GFP around dying cell in a ced-6(qx17) embryo treated with mtm-1 RNAi.The duration of CED-1::GFP around a cell corpse in a mtm-1 RNAi-treated ced-6(qx17) embryo is shown. The cell corpse followed is indicated by an arrow. The frames were collected every 1 min and displayed every 1 sec. Selected images are shown in Figure 4C.
(0.52 MB AVI)
We thank Drs. Ding Xue for providing the smIs34 and smIs95 strains, K. S. Ravichandran, and M.O. Hengartner for providing the opIs334 strain and A. Fire for vectors. We thank Dr. David Sherwood and Dr. Guangshuo Ou for sharing information about myri::mcherry and Dr. Karen Oegema for the pAA65 vector. We thank the C. elegans gene knockout consortium for generating deletion mutants of piki-1, mtm-1, mtm-5 and mtm-6 and the Caenorhabditis Genetic Center (CGC) for strains. We thank C. Zhan and L. Wang for the SLM 510 confocal microscope, Dr. C.L. Yang for his critical reading of the manuscript, Dr. Isabel Hanson for editing services, and members of our laboratory for helpful discussion and suggestion.
Conceived and designed the experiments: WZ QL XW. Performed the experiments: WZ QL. Analyzed the data: WZ QL XW. Contributed reagents/materials/analysis tools: JM. Wrote the paper: XW. Contributed to some of the experiments: DZ, WL, YX.
- 1. Savill J, Dransfield I, Gregory C, Haslett C (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965–975.
- 2. Zhou Z, Hartwieg E, Horvitz HR (2001) CED-1 is a transmembrane receptor that mediates cell corpse engulfment in C. elegans. Cell 104: 43–56.
- 3. Liu QA, Hengartner MO (1998) Candidate adaptor protein CED-6 promotes the engulfment of apoptotic cells in C. elegans. Cell 93: 961–972.
- 4. Wu YC, Horvitz HR (1998) The C. elegans cell corpse engulfment gene ced-7 encodes a protein similar to ABC transporters. Cell 93: 951–960.
- 5. Yu X, Odera S, Chuang CH, Lu N, Zhou Z (2006) C. elegans Dynamin mediates the signaling of phagocytic receptor CED-1 for the engulfment and degradation of apoptotic cells. Dev Cell 10: 743–757.
- 6. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, et al. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405: 85–90.
- 7. Gumienny TL, Brugnera E, Tosello-Trampont AC, Kinchen JM, Haney LB, et al. (2001) CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell 107: 27–41.
- 8. Reddien PW, Horvitz HR (2000) CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat Cell Biol 2: 131–136.
- 9. Wang X, Wu YC, Fadok VA, Lee MC, Gengyo-Ando K, et al. (2003) Cell corpse engulfment mediated by C. elegans phosphatidylserine receptor through CED-5 and CED-12. Science 302: 1563–1566.
- 10. Wu YC, Horvitz HR (1998) C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180. Nature 392: 501–504.
- 11. Wu YC, Tsai MC, Cheng LC, Chou CJ, Weng NY (2001) C. elegans CED-12 acts in the conserved crkII/DOCK180/Rac pathway to control cell migration and cell corpse engulfment. Dev Cell 1: 491–502.
- 12. Zhou Z, Caron E, Hartwieg E, Hall A, Horvitz HR (2001) The C. elegans PH domain protein CED-12 regulates cytoskeletal reorganization via a Rho/Rac GTPase signaling pathway. Dev Cell 1: 477–489.
- 13. Kinchen JM, Cabello J, Klingele D, Wong K, Feichtinger R, et al. (2005) Two pathways converge at CED-10 to mediate actin rearrangement and corpse removal in C. elegans. Nature 434: 93–99.
- 14. Feller SM (2001) Crk family adaptors-signalling complex formation and biological roles. Oncogene 20: 6348–6371.
- 15. Brugnera E, Haney L, Grimsley C, Lu M, Walk SF, et al. (2002) Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex. Nat Cell Biol 4: 574–582.
- 16. deBakker CD, Haney LB, Kinchen JM, Grimsley C, Lu M, et al. (2004) Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO. Curr Biol 14: 2208–2216.
- 17. Laporte J, Bedez F, Bolino A, Mandel JL (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum Mol Genet 12 Spec No 2: R285–292.
- 18. Azzedine H, Bolino A, Taieb T, Birouk N, Di Duca M, et al. (2003) Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am J Hum Genet 72: 1141–1153.
- 19. Laporte J, Hu LJ, Kretz C, Mandel JL, Kioschis P, et al. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 13: 175–182.
- 20. Bolino A, Muglia M, Conforti FL, LeGuern E, Salih MA, et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat Genet 25: 17–19.
- 21. Robinson FL, Dixon JE (2006) Myotubularin phosphatases: policing 3-phosphoinositides. Trends Cell Biol 16: 403–412.
- 22. Robinson FL, Dixon JE (2005) The phosphoinositide-3-phosphatase MTMR2 associates with MTMR13, a membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease. J Biol Chem 280: 31699–31707.
- 23. Nandurkar HH, Layton M, Laporte J, Selan C, Corcoran L, et al. (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc Natl Acad Sci U S A 100: 8660–8665.
- 24. Dang H, Li Z, Skolnik EY, Fares H (2004) Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol Biol Cell 15: 189–196.
- 25. Kim SA, Vacratsis PO, Firestein R, Cleary ML, Dixon JE (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc Natl Acad Sci U S A 100: 4492–4497.
- 26. Berger P, Berger I, Schaffitzel C, Tersar K, Volkmer B, et al. (2006) Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. Hum Mol Genet 15: 569–579.
- 27. Parrish WR, Stefan CJ, Emr SD (2004) Essential role for the myotubularin-related phosphatase Ymr1p and the synaptojanin-like phosphatases Sjl2p and Sjl3p in regulation of phosphatidylinositol 3-phosphate in yeast. Mol Biol Cell 15: 3567–3579.
- 28. Taylor GS, Maehama T, Dixon JE (2000) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci U S A 97: 8910–8915.
- 29. Kim SA, Taylor GS, Torgersen KM, Dixon JE (2002) Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J Biol Chem 277: 4526–4531.
- 30. Walker DM, Urbe S, Dove SK, Tenza D, Raposo G, et al. (2001) Characterization of MTMR3. an inositol lipid 3-phosphatase with novel substrate specificity. Curr Biol 11: 1600–1605.
- 31. Berger P, Bonneick S, Willi S, Wymann M, Suter U (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. Hum Mol Genet 11: 1569–1579.
- 32. Schaletzky J, Dove SK, Short B, Lorenzo O, Clague MJ, et al. (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Curr Biol 13: 504–509.
- 33. Blondeau F, Laporte J, Bodin S, Superti-Furga G, Payrastre B, et al. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum Mol Genet 9: 2223–2229.
- 34. Vanhaesebroeck B, Leevers SJ, Ahmadi K, Timms J, Katso R, et al. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 70: 535–602.
- 35. Clague MJ, Lorenzo O (2005) The myotubularin family of lipid phosphatases. Traffic 6: 1063–1069.
- 36. Xue Y, Fares H, Grant B, Li Z, Rose AM, et al. (2003) Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J Biol Chem 278: 34380–34386.
- 37. Tsujita K, Itoh T, Ijuin T, Yamamoto A, Shisheva A, et al. (2004) Myotubularin regulates the function of the late endosome through the gram domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol Chem 279: 13817–13824.
- 38. Cao C, Backer JM, Laporte J, Bedrick EJ, Wandinger-Ness A (2008) Sequential actions of myotubularin lipid phosphatases regulate endosomal PTDINS(3)P and growth factor receptor trafficking. Mol Biol Cell 19: 3334–3346.
- 39. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207–2216.
- 40. Darland-Ransom M, Wang X, Sun CL, Mapes J, Gengyo-Ando K, et al. (2008) Role of C. elegans TAT-1 protein in maintaining plasma membrane phosphatidylserine asymmetry. Science 320: 528–531.
- 41. Wang X, Wang J, Gengyo-Ando K, Gu L, Sun CL, et al. (2007) C. elegans mitochondrial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1. Nat Cell Biol 9: 541–549.
- 42. Zhou Z, Yu X (2008) Phagosome maturation during the removal of apoptotic cells: receptors lead the way. Trends Cell Biol 18: 474–485.
- 43. Yu X, Lu N, Zhou Z (2008) Phagocytic receptor CED-1 initiates a signaling pathway for degrading engulfed apoptotic cells. PLoS Biol 6: e61. doi:10.1371/journal.pbio.0060061.
- 44. Kinchen JM, Doukoumetzidis K, Almendinger J, Stergiou L, Tosello-Trampont A, et al. (2008) A pathway for phagosome maturation during engulfment of apoptotic cells. Nat Cell Biol 10: 556–566.
- 45. Laporte J, Blondeau F, Gansmuller A, Lutz Y, Vonesch JL, et al. (2002) The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J Cell Sci 115: 3105–3117.
- 46. Dowling JJ, Vreede AP, Low SE, Gibbs EM, Kuwada JY, et al. (2009) Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet 5: e1000372. doi:10.1371/journal.pgen.1000372.
- 47. Hedgecock EM, Culotti JG, Hall DH, Stern BD (1987) Genetics of cell and axon migrations in Caenorhabditis elegans. Development 100: 365–382.
- 48. Kimble J (1981) Alterations in cell lineage following laser ablation of cells in the somatic gonad of Caenorhabditis elegans. Dev Biol 87: 286–300.
- 49. Lundquist EA, Reddien PW, Hartwieg E, Horvitz HR, Bargmann CI (2001) Three C. elegans Rac proteins and several alternative Rac regulators control axon guidance, cell migration and apoptotic cell phagocytosis. Development 128: 4475–4488.
- 50. Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, et al. (2003) Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidylinositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 17: 2448–2460.
- 51. Maffucci T, Cooke FT, Foster FM, Traer CJ, Fry MJ, et al. (2005) Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration. J Cell Biol 169: 789–799.
- 52. Brown RA, Shepherd PR (2001) Growth factor regulation of the novel class II phosphoinositide 3-kinases. Biochem Soc Trans 29: 535–537.
- 53. Tissenbaum HA, Ruvkun G (1998) An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics 148: 703–717.
- 54. Roggo L, Bernard V, Kovacs AL, Rose AM, Savoy F, et al. (2002) Membrane transport in Caenorhabditis elegans: an essential role for VPS34 at the nuclear membrane. Embo J 21: 1673–1683.
- 55. Conradt B, Horvitz HR (1998) The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 93: 519–529.
- 56. Diez-Roux G, Lang RA (1997) Macrophages induce apoptosis in normal cells in vivo. Development 124: 3633–3638.
- 57. Lang RA, Bishop JM (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74: 453–462.
- 58. Little GH, Flores A (1993) Inhibition of programmed cell death by catalase and phenylalanine methyl ester. Comp Biochem Physiol Comp Physiol 105: 79–83.
- 59. Reddien PW, Cameron S, Horvitz HR (2001) Phagocytosis promotes programmed cell death in C. elegans. Nature 412: 198–202.
- 60. Hoeppner DJ, Hengartner MO, Schnabel R (2001) Engulfment genes cooperate with ced-3 to promote cell death in Caenorhabditis elegans. Nature 412: 202–206.
- 61. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, et al. (2005) Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123: 321–334.
- 62. Tosello-Trampont AC, Nakada-Tsukui K, Ravichandran KS (2003) Engulfment of apoptotic cells is negatively regulated by Rho-mediated signaling. J Biol Chem 278: 49911–49919.
- 63. Nakaya M, Tanaka M, Okabe Y, Hanayama R, Nagata S (2006) Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages. J Biol Chem 281: 8836–8842.
- 64. Hurwitz ME, Vanderzalm PJ, Bloom L, Goldman J, Garriga G, et al. (2009) Abl kinase inhibits the engulfment of apoptotic cells in Caenorhabditis elegans. PLoS Biol 7: e99. doi:10.1371/journal.pbio.1000099.
- 65. Cao C, Laporte J, Backer JM, Wandinger-Ness A, Stein MP (2007) Myotubularin lipid phosphatase binds the hVPS15/hVPS34 lipid kinase complex on endosomes. Traffic 8: 1052–1067.
- 66. Cote JF, Motoyama AB, Bush JA, Vuori K (2005) A novel and evolutionarily conserved PtdIns(3,4,5)P3-binding domain is necessary for DOCK180 signalling. Nat Cell Biol 7: 797–807.
- 67. Ren XD, Schwartz MA (1998) Regulation of inositol lipid kinases by Rho and Rac. Curr Opin Genet Dev 8: 63–67.
- 68. Buj-Bello A, Laugel V, Messaddeq N, Zahreddine H, Laporte J, et al. (2002) The lipid phosphatase myotubularin is essential for skeletal muscle maintenance but not for myogenesis in mice. Proc Natl Acad Sci U S A 99: 15060–15065.
- 69. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71–94.
- 70. Riddle DL, Blumenthal T, Meyer BJ, Priess JR (1997) C. elegans II. Plainview, New York: Cold Spring harvor Laboratory Press.
- 71. Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, et al. (2002) Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Curr Biol 12: 1317–1319.
- 72. Zipkin ID, Kindt RM, Kenyon CJ (1997) Role of a new Rho family member in cell migration and axon guidance in C. elegans. Cell 90: 883–894.
- 73. Sulston JE, Horvitz HR (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol 56: 110–156.
- 74. Sulston JE, Schierenberg E, White JG, Thomson JN (1983) The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev Biol 100: 64–119.
- 75. Stanfield GM, Horvitz HR (2000) The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol Cell 5: 423–433.
- 76. Kamath RS, Ahringer J (2003) Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30: 313–321.
- 77. Green RA, Audhya A, Pozniakovsky A, Dammermann A, Pemble H, et al. (2008) Expression and imaging of fluorescent proteins in the C. elegans gonad and early embryo. Methods Cell Biol 85: 179–218.